Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of$ 0.41. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -9.76%. A quarter ago, it was expected that this company would post a loss of$ 0.40 per share when it actually produced a loss of $0.38, delivering a surprise of 5%. Over the last four quarters, the compan ...